• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菲烯和苊衍生物的合成作为褪黑素受体新的构象受限配体

Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.

作者信息

Jellimann C, Mathé-Allainmat M, Andrieux J, Kloubert S, Boutin J A, Nicolas J P, Bennejean C, Delagrange P, Langlois M

机构信息

Faculté de Pharmacie, Université de Paris-Sud, CNRS-BIOCIS (UPRES A 8076), 5 rue J. B. Clément, 92296 Châtenay-Malabry, France.

出版信息

J Med Chem. 2000 Nov 2;43(22):4051-62. doi: 10.1021/jm000922c.

DOI:10.1021/jm000922c
PMID:11063602
Abstract

Conformationally restricted phenalene and acenaphthene derivatives 5 were synthesized from phenalen-1-one and acenaphthen-1-one derivatives using the Horner-Emmons reaction. The amines were prepared through the corresponding isocyanates by the Curtius reaction on the acids or by the reduction of the nitriles. Amido derivatives (R(3) = Me, Et, n-Pr, c-Pr) were prepared by acylation of the amines with the appropriate anhydrides or acid chlorides or by the reductive acylation of the nitriles. The affinities of the compounds for melatonin binding sites were evaluated in vitro in binding assays using chicken brain melatonin and the human mt(1) and MT(2) receptors expressed in HEK-293 cells. The functionality of the compounds was determined by the potency to lighten the skin of Xenopus laevis tadpoles. Highly potent compounds were obtained. The data highlighted the role of the methoxy group located in the ortho position to the ethylamido chain as compounds with picomolar affinities such as 14c were obtained (chicken brain, hmt(1), hMT(2) K(i) values = 0.02, 0.008, 0.069 nM, respectively). Compound 14c was equipotent to the corresponding dimethoxy derivative 15c (chicken brain, hmt(1), hMT(2) K(i) values = 0.07, 0.016, 0.1 nM, respectively). On the other hand, the restricted conformation of the amido chain did not influence selectivity for the cloned hmt(1) and hMT(2) receptors. These compounds were also potent agonists of melanophore aggregation in X. laevis. 15a,c were several hundred fold more potent than melatonin (EC(50) = 0.025, 0.004 nM, respectively). Conformational studies indicated that the minimum energy folded conformation of the ethylamido chain could constitute the putative active form in the receptor site in agreement with previous results.

摘要

通过霍纳-埃蒙斯反应,由菲-1-酮和苊-1-酮衍生物合成了构象受限的菲和苊衍生物5。胺是通过相应的异氰酸酯,由酸上的库尔提斯反应或腈的还原制备的。酰胺衍生物(R(3)=甲基、乙基、正丙基、环丙基)是通过用适当的酸酐或酰氯对胺进行酰化,或通过腈的还原酰化制备的。使用鸡脑褪黑素以及在HEK-293细胞中表达的人mt(1)和MT(2)受体,通过结合试验在体外评估了这些化合物对褪黑素结合位点的亲和力。通过使非洲爪蟾蝌蚪皮肤变浅的效力来确定这些化合物的功能。获得了高效能的化合物。数据突出了位于乙酰胺链邻位的甲氧基的作用,因为获得了具有皮摩尔亲和力的化合物,如14c(鸡脑、hmt(1)、hMT(2)的K(i)值分别为0.02、0.008、0.069 nM)。化合物14c与相应的二甲氧基衍生物15c效力相当(鸡脑、hmt(1)、hMT(2)的K(i)值分别为0.07、0.016、0.1 nM)。另一方面,酰胺链的受限构象不影响对克隆的hmt(1)和hMT(2)受体的选择性。这些化合物也是非洲爪蟾中黑素细胞聚集的有效激动剂。15a、c的效力比褪黑素高几百倍(EC(50)分别为0.025、0.004 nM)。构象研究表明,乙酰胺链的最低能量折叠构象可能构成受体位点中的假定活性形式,这与先前的结果一致。

相似文献

1
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.菲烯和苊衍生物的合成作为褪黑素受体新的构象受限配体
J Med Chem. 2000 Nov 2;43(22):4051-62. doi: 10.1021/jm000922c.
2
Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.N-(4-甲氧基-2,3-二氢-1H-菲-2-基)酰胺衍生物的(+)-和(-)-对映体的褪黑素能特性
J Med Chem. 1999 Mar 25;42(6):1100-5. doi: 10.1021/jm9804937.
3
Synthesis of new arylalkoxy amido derivatives as melatoninergic ligands.
Bioorg Med Chem. 2003 Mar 6;11(5):789-800. doi: 10.1016/s0968-0896(02)00328-0.
4
Synthesis of beta-substituted naphth-1-yl ethylamido derivatives as new melatoninergic agonists.新型褪黑素能激动剂β-取代萘-1-基乙酰胺衍生物的合成
Bioorg Med Chem. 1999 Dec;7(12):2945-52. doi: 10.1016/s0968-0896(99)00236-9.
5
Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.2-酰胺基-2,3-二氢-1H-菲衍生物的合成:作为褪黑素受体新型构象受限配体
J Med Chem. 1996 Aug 2;39(16):3089-95. doi: 10.1021/jm960219h.
6
Synthesis of benzocycloalkane derivatives as new conformationally restricted ligands for melatonin receptors.苯并环烷衍生物作为褪黑素受体新型构象受限配体的合成
Bioorg Med Chem Lett. 1998 Dec 1;8(23):3325-30. doi: 10.1016/s0960-894x(98)00601-5.
7
Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.褪黑素受体的图谱绘制。6. 源自6H-异吲哚并[2,1-a]吲哚、5,6-二氢吲哚并[2,1-a]异喹啉以及6,7-二氢-5H-苯并[c]氮杂环庚并[2,1-a]吲哚的褪黑素激动剂和拮抗剂。
J Med Chem. 2000 Mar 23;43(6):1050-61. doi: 10.1021/jm980684+.
8
Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.褪黑素受体的定位。5. 源自四氢环戊[b]吲哚、四氢咔唑和六氢环庚[b]吲哚的褪黑素激动剂和拮抗剂。
J Med Chem. 1998 Feb 12;41(4):451-67. doi: 10.1021/jm970246n.
9
Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: a comparative molecular field analysis study.褪黑素受体配体的三维定量构效关系:一项比较分子场分析研究
J Med Chem. 1997 Feb 28;40(5):739-48. doi: 10.1021/jm960680+.
10
Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt1 and MT2 receptors.
Bioorg Med Chem. 2000 Jan;8(1):163-71. doi: 10.1016/s0968-0896(99)00285-0.

引用本文的文献

1
The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry.库尔提乌斯重排反应:在现代药物发现和药物化学中的应用。
ChemMedChem. 2018 Nov 20;13(22):2351-2373. doi: 10.1002/cmdc.201800518. Epub 2018 Oct 11.
2
Discovery of 7-hydroxyaporphines as conformationally restricted ligands for beta-1 and beta-2 adrenergic receptors.发现7-羟基阿朴啡作为β-1和β-2肾上腺素能受体的构象受限配体。
Medchemcomm. 2018 Jan 22;9(2):353-356. doi: 10.1039/c7md00656j. eCollection 2018 Feb 1.
3
(1S,1'S,2'R,4a'S,9a'S,9b'R)-1'-Acet-yloxy-2,4'-dioxo-2',4',4a',7',8',9',9a',9b'-octa-hydro-1'H,2H-spiro-[ace-naphthyl-ene-1,5'-pyrano[4,3-a]pyrrolizin]-2'-ylmethyl acetate.
(1S,1'S,2'R,4a'S,9a'S,9b'R)-1'-乙酰氧基-2,4'-二氧代-2',4',4a',7',8',9',9a',9b'-八氢-1'H,2H-螺[苊烯-1,5'-吡喃并[4,3-a]吡咯嗪]-2'-基甲基乙酸酯
Acta Crystallogr Sect E Struct Rep Online. 2013 Oct 2;69(Pt 11):o1601. doi: 10.1107/S1600536813026111.
4
Novel 9-(alkylthio)-Acenaphtho[1,2-e]-1,2,4-triazine derivatives: synthesis, cytotoxic activity and molecular docking studies on B-cell lymphoma 2 (Bcl-2).新型 9-(烷基硫基)-吖[1,2-e]-1,2,4-三嗪衍生物的合成、细胞毒性活性及对 B 细胞淋巴瘤 2 (Bcl-2) 的分子对接研究。
Daru. 2014 Jan 6;22(1):2. doi: 10.1186/2008-2231-22-2.
5
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.国际基础与临床药理学联合会. LXXV. G 蛋白偶联褪黑素受体的命名、分类和药理学。
Pharmacol Rev. 2010 Sep;62(3):343-80. doi: 10.1124/pr.110.002832. Epub 2010 Jul 6.
6
New selective ligands of human cloned melatonin MT1 and MT2 receptors.人克隆褪黑素MT1和MT2受体的新型选择性配体。
Naunyn Schmiedebergs Arch Pharmacol. 2003 Jun;367(6):553-61. doi: 10.1007/s00210-003-0751-2. Epub 2003 May 23.